What is Chardan Capital’s Estimate for ALUR FY2025 Earnings?

Allurion Technologies, Inc. (NYSE:ALUR) – Research analysts at Chardan Capital decreased their FY2025 earnings per share estimates for shares of Allurion Technologies in a research report issued on Wednesday, September 3rd. Chardan Capital analyst K. Nakae now expects that the company will earn ($3.45) per share for the year, down from their previous estimate of ($2.08). The consensus estimate for Allurion Technologies’ current full-year earnings is ($9.96) per share. Chardan Capital also issued estimates for Allurion Technologies’ FY2026 earnings at ($2.06) EPS.

Allurion Technologies (NYSE:ALUR) last posted its quarterly earnings results on Tuesday, August 19th. The company reported ($0.57) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.65) by $0.08. The company had revenue of $3.38 million during the quarter, compared to analyst estimates of $6.20 million.

Several other analysts also recently commented on the company. Zacks Research raised Allurion Technologies to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen downgraded Allurion Technologies from a “hold” rating to a “strong sell” rating in a research note on Saturday, August 16th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Allurion Technologies has an average rating of “Moderate Buy” and an average price target of $22.83.

Allurion Technologies Trading Up 3.4%

Shares of Allurion Technologies stock opened at $2.20 on Monday. The company has a market capitalization of $17.10 million, a PE ratio of -0.18 and a beta of -0.46. Allurion Technologies has a 12 month low of $1.98 and a 12 month high of $22.25. The stock’s fifty day simple moving average is $2.61 and its 200 day simple moving average is $2.65.

Hedge Funds Weigh In On Allurion Technologies

A hedge fund recently bought a new stake in Allurion Technologies stock. XTX Topco Ltd acquired a new stake in Allurion Technologies, Inc. (NYSE:ALUR) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 13,037 shares of the company’s stock, valued at approximately $42,000. XTX Topco Ltd owned approximately 0.27% of Allurion Technologies at the end of the most recent reporting period. 21.39% of the stock is owned by institutional investors and hedge funds.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.